CO2019000513A2 - Formas cristalinas de un compuesto de tetraciclina sustituido con 9-aminometilo y un método de preparación de las mismas - Google Patents
Formas cristalinas de un compuesto de tetraciclina sustituido con 9-aminometilo y un método de preparación de las mismasInfo
- Publication number
- CO2019000513A2 CO2019000513A2 CONC2019/0000513A CO2019000513A CO2019000513A2 CO 2019000513 A2 CO2019000513 A2 CO 2019000513A2 CO 2019000513 A CO2019000513 A CO 2019000513A CO 2019000513 A2 CO2019000513 A2 CO 2019000513A2
- Authority
- CO
- Colombia
- Prior art keywords
- crystalline forms
- aminomethyl
- preparation
- compound substituted
- tetracycline compound
- Prior art date
Links
- 239000004098 Tetracycline Substances 0.000 title abstract 4
- 229960002180 tetracycline Drugs 0.000 title abstract 4
- 229930101283 tetracycline Natural products 0.000 title abstract 4
- 235000019364 tetracycline Nutrition 0.000 title abstract 4
- -1 tetracycline compound Chemical group 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 3
- 241000894006 Bacteria Species 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000003522 tetracyclines Chemical class 0.000 abstract 2
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/54—Spiro-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Abstract
La presente invención pertenece al campo de la tecnología farmacéutica, y formas cristalinas de un compuesto de tetraciclina sustituido con 9-aminometilo y un proceso para preparar las mismas. Más específicamente, la presente invención se relaciona con formas cristalinas del compuesto representado por la fórmula (1), un proceso para preparar formas cristalinas del compuesto representado por la fórmula (1) y el uso de dichas formas cristalinas en la fabricación de medicamento para tratar y/o prevenir una enfermedad infecciosa causada por bacterias sensibles a la tetraciclina y/o bacterias resistentes a la tetraciclina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610457261 | 2016-06-22 | ||
| PCT/CN2017/089470 WO2017219994A1 (zh) | 2016-06-22 | 2017-06-22 | 9-氨基甲基取代的四环素类化合物的晶型及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2019000513A2 true CO2019000513A2 (es) | 2019-04-30 |
Family
ID=60783195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2019/0000513A CO2019000513A2 (es) | 2016-06-22 | 2019-01-18 | Formas cristalinas de un compuesto de tetraciclina sustituido con 9-aminometilo y un método de preparación de las mismas |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US10633337B2 (es) |
| EP (1) | EP3476831B8 (es) |
| JP (1) | JP6883593B2 (es) |
| KR (1) | KR102205843B1 (es) |
| CN (1) | CN109563035B (es) |
| AU (1) | AU2017282891B2 (es) |
| CA (1) | CA3028014C (es) |
| CL (1) | CL2018003739A1 (es) |
| CO (1) | CO2019000513A2 (es) |
| ES (1) | ES2906885T3 (es) |
| IL (1) | IL263868B (es) |
| MA (1) | MA45461A (es) |
| MX (1) | MX381701B (es) |
| MY (1) | MY186900A (es) |
| PE (1) | PE20190810A1 (es) |
| PH (1) | PH12018502680A1 (es) |
| RU (2) | RU2764723C2 (es) |
| SG (1) | SG11201811499WA (es) |
| TW (1) | TWI656116B (es) |
| WO (1) | WO2017219994A1 (es) |
| ZA (1) | ZA201900274B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD962414S1 (en) | 2020-02-28 | 2022-08-30 | Beijing Xiaomi Mobile Software Co., Ltd | Fan |
| EP4165016A4 (en) * | 2020-06-11 | 2024-07-10 | Paratek Pharmaceuticals, Inc. | CRYSTALLINE FORMS OF OMADACYCLINE, METHODS FOR THEIR SYNTHESIS AND METHODS FOR THEIR USE |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004064728A2 (en) * | 2003-01-16 | 2004-08-05 | Paratek Pharmaceuticals, Inc. | Use of specific tetracycline compounds in therapy |
| AR057649A1 (es) * | 2005-05-27 | 2007-12-12 | Wyeth Corp | Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas |
| CA2704536C (en) * | 2007-11-14 | 2017-04-25 | Sandoz Ag | Crystalline forms of tigecycline hydrochloride |
| WO2009092680A2 (en) * | 2008-01-23 | 2009-07-30 | Sandoz Ag | Antibiotic compounds |
| TWI680117B (zh) * | 2008-05-19 | 2019-12-21 | 派洛泰克藥物股份有限公司 | 四環素化合物之甲苯磺酸鹽及同素異形體 |
| CN103717571B8 (zh) * | 2011-07-26 | 2017-05-17 | 山东亨利医药科技有限责任公司 | 9‑氨基甲基取代的四环素类化合物 |
| CN102417465B (zh) | 2011-10-27 | 2014-03-12 | 宫宁瑞 | 替加环素新晶型及其制备方法 |
-
2017
- 2017-06-22 JP JP2018567683A patent/JP6883593B2/ja active Active
- 2017-06-22 KR KR1020187037477A patent/KR102205843B1/ko active Active
- 2017-06-22 SG SG11201811499WA patent/SG11201811499WA/en unknown
- 2017-06-22 TW TW106120947A patent/TWI656116B/zh active
- 2017-06-22 RU RU2019101248A patent/RU2764723C2/ru active
- 2017-06-22 CA CA3028014A patent/CA3028014C/en active Active
- 2017-06-22 CN CN201780026902.4A patent/CN109563035B/zh active Active
- 2017-06-22 WO PCT/CN2017/089470 patent/WO2017219994A1/zh not_active Ceased
- 2017-06-22 IL IL263868A patent/IL263868B/en unknown
- 2017-06-22 RU RU2022100160A patent/RU2022100160A/ru unknown
- 2017-06-22 MY MYPI2018002825A patent/MY186900A/en unknown
- 2017-06-22 AU AU2017282891A patent/AU2017282891B2/en active Active
- 2017-06-22 ES ES17814732T patent/ES2906885T3/es active Active
- 2017-06-22 PE PE2018003293A patent/PE20190810A1/es unknown
- 2017-06-22 EP EP17814732.8A patent/EP3476831B8/en active Active
- 2017-06-22 US US16/312,404 patent/US10633337B2/en active Active
- 2017-06-22 MA MA045461A patent/MA45461A/fr unknown
- 2017-06-22 MX MX2019000086A patent/MX381701B/es unknown
-
2018
- 2018-12-18 PH PH12018502680A patent/PH12018502680A1/en unknown
- 2018-12-21 CL CL2018003739A patent/CL2018003739A1/es unknown
-
2019
- 2019-01-15 ZA ZA2019/00274A patent/ZA201900274B/en unknown
- 2019-01-18 CO CONC2019/0000513A patent/CO2019000513A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2020000501A1 (es) | Inhibidores de la ectonucleótido pirofosfatasa-fosfodiesterasa 1 (enpp1) y usos de los mismos. | |
| MX2017002028A (es) | Compuestos de pirrolopirimidina usados como agonista del receptor de tipo toll 7 (tlr7). | |
| MX2017010933A (es) | Compuestos antivirales. | |
| MX2018007022A (es) | Metodos para tratar la enfermedad de huntington. | |
| MX375170B (es) | Compuestos de amida para el tratamiento de vih. | |
| CL2016001120A1 (es) | Compuestos derivados de pirrolo1,2-f1,2,4triazina ,composición farmacéutica que los comprende y su uso en el tratamiento de una infección por virus sincicial compuestos intermediarios. pct | |
| BR112017001565A2 (pt) | ?composto, métodos para tratar uma infecção e para fabricar um medicamento, composição farmacêutica, e, uso de um composto? | |
| BR112017023263A2 (pt) | compostos antivirais rsv de pirazolo e triazolopirimidina | |
| CR20150611A (es) | Novedosas heteroarildihidropirimidinas unidas por puentes en 6 para el tratamiento y la profilaxis por el virus de la hepatitis b | |
| MX2020004785A (es) | Proceso para preparar tapinarof. | |
| BR112017023740A2 (pt) | ?forma sólida de um composto, processo para a preparação de uma forma sólida, composição farmacêutica, método para o tratamento ou prevenção de doenças e utilização de uma forma sólida? | |
| BR112014022214A2 (pt) | fenólicos antibacterianos | |
| DOP2016000308A (es) | Compuestos de 1, 3, 4-tiadiazol y uso de los mismos para el tratamiento del cáncer | |
| UY36737A (es) | 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas | |
| MX2014005342A (es) | Inhibidores del virus de la hepatitis c. | |
| BR112017003242A2 (pt) | composto, métodos para tratar infecção por vírus e para fabricação de um medicamento, composição farmacêutica, e, uso de um composto. | |
| BR112016016853A2 (pt) | Compostos contendo nitrogênio, seu uso e seu processo de preparação, composição farmacêutica e seu uso | |
| MX2017009094A (es) | Derivado de polimixina y usos del mismo. | |
| DOP2016000278A (es) | Nuevos compuestos macrocíclicos | |
| NI201800071A (es) | Compuestos de isoindol | |
| BR112017003663A2 (pt) | composto, composição, e, método para tratamento de infecção por hiv. | |
| MX2019013291A (es) | Compuestos y metodos para tratar infecciones bacterianas. | |
| CO2018007008A2 (es) | "procesos mejorados para la preparación de osimertinib (azd9291) o una sal del mismo y "azd9291 anilina" o una sal del mismo" | |
| MX2017003788A (es) | Derivados de nucleósidos sustituidos con 4´-vinilo como inhibidores de la replicación del arn del virus respiratorio sincitial. | |
| CO2019000513A2 (es) | Formas cristalinas de un compuesto de tetraciclina sustituido con 9-aminometilo y un método de preparación de las mismas |